Compare TEVA & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | LDOS |
|---|---|---|
| Founded | 1901 | 1969 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 24.7B |
| IPO Year | N/A | 2006 |
| Metric | TEVA | LDOS |
|---|---|---|
| Price | $31.80 | $193.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $32.67 | ★ $213.73 |
| AVG Volume (30 Days) | ★ 9.2M | 861.7K |
| Earning Date | 01-28-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 0.88% |
| EPS Growth | N/A | ★ 22.34 |
| EPS | 0.62 | ★ 10.68 |
| Revenue | $16,776,000,000.00 | ★ $17,332,000,000.00 |
| Revenue This Year | $4.62 | $5.70 |
| Revenue Next Year | $0.34 | $3.73 |
| P/E Ratio | $51.46 | ★ $18.22 |
| Revenue Growth | 0.02 | ★ 6.48 |
| 52 Week Low | $12.47 | $123.62 |
| 52 Week High | $33.42 | $205.77 |
| Indicator | TEVA | LDOS |
|---|---|---|
| Relative Strength Index (RSI) | 59.77 | 54.59 |
| Support Level | $31.92 | $188.26 |
| Resistance Level | $32.86 | $205.00 |
| Average True Range (ATR) | 0.74 | 6.18 |
| MACD | -0.21 | 0.41 |
| Stochastic Oscillator | 43.90 | 56.32 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.